Take the CURE Magazine Survey

Ojemda treatment for certain patients with pediatric low-grade glioma is “well-tolerated” and may be safer than traditional options, an expert told CURE®.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

As a society, we shouldn't accept the "norm" of people younger than 50 receiving diagnoses or dying from cancer.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

I watched my family members go through breast and ovarian cancer diagnoses, and knew that one day, I’d have my own major medical decisions to make.

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy.